Suchergebnisse - "Simonetti, Giorgia"

PubPharm (146)

101

Short course radiotherapy concomitant with temozolomide in GBM patients : a phase II study

enthalten in: Tumori | 2017

von Fariselli, L. | Cuppini, L. | Gaviani, P. | +8

102

Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells

enthalten in: Haematologica | 2017

von Daniele, G. | Simonetti, G. | Fusilli, C. | +23

103

5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia

enthalten in: Journal of hematology & oncology | 2017

von Marconi, C. | Canobbio, I. | Bozzi, V. | +10

104

5’UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia

enthalten in: Journal of hematology & oncology | 2017

von Marconi, C. | Canobbio, I. | Bozzi, V. | +10

105

Efficacy of Azacitidine in the treatment of adult patients aged 65 years or older with AML

enthalten in: Expert opinion on pharmacotherapy | 2016

von Tenti, E. | Papayannidis, C. | Marconi, G. | +7

106

Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data

enthalten in: BMC bioinformatics | 2016

von do Valle, �. | Giampieri, E. | Simonetti, G. | +11

107

Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data

enthalten in: BMC bioinformatics | 2016

von do Valle, �. | Giampieri, E. | Simonetti, G. | +11

108

Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data

enthalten in: BMC bioinformatics | 2016

von do Valle, �. | Giampieri, E. | Simonetti, G. | +11

109

The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells

enthalten in: Oncotarget | 2016

von Giordani, G. | Barraco, M. | Giangrande, A. | +5

110

Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a : a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients

enthalten in: Oncotarget | 2016

von Trino, S. | Iacobucci, I. | Erriquez, D. | +16